<DOC>
	<DOCNO>NCT01779778</DOCNO>
	<brief_summary>The purpose research study determine diurnal nocturnal effect Travoprost SofZia ( Travatan Z ) intraocular pressure ocular perfusion pressure .</brief_summary>
	<brief_title>Diurnal Nocturnal Effect Travatan With SofZia Preservative Intraocular Pressure Ocular Perfusion Pressure</brief_title>
	<detailed_description>The investigator hypothesize Travatan Z significantly low intraocular pressure increase ocular perfusion pressure diurnal nocturnal period , 24-hour evaluation , compare baseline . The investigator hypothesize medication effect persist 72 hour discontinuation drug .</detailed_description>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<criteria>Diagnosis openangle glaucoma ocular hypertension , include pigment dispersion glaucoma pseudoexfoliation glaucoma Age ≥ 18 ≤ 90 year , either gender , race/ethnicity Females currently pregnant plan become pregnant , determined history study period Diagnosis form glaucoma openangle Schaffer angle grade &lt; 2 either eye gonioscopy Chronic , recurrent , severe inflammatory eye disease Intraocular surgery within 6 month laser within 3 month History active , recurrent , chronic ocular infection Herpes Simplex Virus History cystoid macular edema Inability safely discontinue ocular medication 4 week Patients smoke irregular daily sleep pattern Patients start changed glucocorticoid therapy last 3 month Patients currently undergo medical marijuana therapy Any use nonFDA approve medication glaucoma last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>